EmmaGuttmanMD

Dermatology • New York, NY

Sol and Clara Kest Professor, Dermatology, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Guttman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Guttman's full profile

Already have an account?

Office
5 E 98th St Fl 5
New York, NY 10029
Phone+1 212-241-9065

Fax+1 212-348-7434
Is this information wrong?

Education & Training

Tel Aviv University SacklerClass of 1998
New York Presbyterian Hospital (Cornell Campus)Residency, Dermatology

Certifications & Licensure

FL State Medical License 2020 - Present
NY State Medical License 2007 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Registry for the Atopic Dermatitis Research Network Start of enrollment: 2011 Aug 01
Completed
Immune Reactions in Contact Dermatitis Affected Skin Start of enrollment: 2012 Jan 01
Completed
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis Start of enrollment: 2013 Jan 01
Recruiting
Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis Start of enrollment: 2013 Mar 01
Completed
Phase 2
Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis Start of enrollment: 2013 Oct 01
Completed
Phase 2
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata Start of enrollment: 2016 Jan 01
Completed
Phase 2
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata Start of enrollment: 2016 Feb 01
Completed
Not Applicable
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses Start of enrollment: 2016 Dec 01
Completed
Phase 2
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) Start of enrollment: 2018 Jan 09
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

29 citations
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Jonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, Alan D Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L Simpson, Chia-Yu Chu, Zhuqing Liu, Renata Gontijo L...> ;The New England Journal of Medicine. 2023 Mar 23
6 citations
Atopic Dermatitis Yardstick update.
Mark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, Peck Y Ong, Jonathan I Silverberg> ;Annals of Allergy, Asthma & Immunology. 2023 Jun 1
13 citations
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, John Nia, Peter Hashim, Giselle K Singer, Alba L Posligua, Aleksandra G Florek, Erin Ibler, Erika L Hagstrom, Yeri...> ;Archives of Dermatological Research. 2023 Mar 1
15 citations
Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, plac...
Robert Bissonnette, William Abramovits, Étienne Saint-Cyr Proulx, Patricia Lee, Emma Guttman-Yassky, Elizabeta Zovko, Ralf Sigmund, Joanne Willcox, Thomas Bieber> ;Journal of the European Academy of Dermatology and Venereology. 2023 Mar 1
1 citations
Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey.
Jonathan I Silverberg, Jennifer A Mohawk, Joshua Cirulli, Kristine Nograles, Joseph C Punzalan, Kevin M Kelly, Brian S Kim, Emma Guttman-Yassky, Mark Lebwohl> ;Dermatitis. 2023 Jan 18
5 citations
Pharmacology of orismilast, a potent and selective PDE4 inhibitor.
Jonathan I Silverberg, Lars E French, Richard B Warren, Bruce Strober, Kim Kjøller, Morten O A Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, ...> ;Journal of the European Academy of Dermatology and Venereology. 2023 Apr 1
7 citations
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets.
Richard B Warren, Bruce Strober, Jonathan I Silverberg, Emma Guttman, Philippe Andres, Jakob Felding, Deniz Tutkunkardas, Kim Kjøller, Morten O A Sommer, Lars E French> ;Journal of the European Academy of Dermatology and Venereology. 2023 Apr 1
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.
Marron, T., Galsky, M., Taouli, B., Fiel, M., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B., Labow, D., Sfak...> ;Nature Medicine. 2022 Aug 1
13 citations
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a rando...
Anne Weiss, Emilie Delavenne, Carina Matias, Heimo Lagler, Daniel Simon, Ping Li, Jon U Hansen, Teresa Pires Dos Santos, Bimal Jana, Petra Priemel, Christine Bangert, ...> ;Clinical and Translational Medicine. 2022 May 1
9 citations
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.
Marron, T., Galsky, M., Taouli, B., Fiel, M., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B., Labow, D., Sfak...> ;Nature Medicine. 2022 Apr 1
4 citations
Good practice intervention for clinical assessment and diagnosis of atopic dermatitis: Findings from the atopic dermatitis quality of care initiative.
Stephan Weidinger, Audrey Nosbaum, Eric Simpson, Emma Guttman> ;Dermatologic Therapy. 2022 Mar 1
4 citations
Scan-rescan measurement repeatability of 18F-FDG PET/MR imaging of vascular inflammation.
Philip M. Robson, Alison Pruzan, Marc R. Dweck, MariaGiovanna Trivieri, Ronan Abgral, Nicolas A. Karakatsanis, Patrick M. Brunner, Emma Guttman, Zahi A. Fayad, Venkate...> ;Journal of Nuclear Cardiology. 2021 May 27
Reply.
Tali Czarnowicki, James G Krueger, Emma Guttman-Yassky> ;The Journal of Allergy and Clinical Immunology. 2016 Jul 1
20 citations
Pathways to managing atopic dermatitis: consensus from the experts.
Mark Lebwohl, James Q Del Rosso, William Abramovits, Brian Berman, David E. Cohen, Emma Guttman, Anthony J. Mancini, Lawrence A. Schachner> ;The Journal of Clinical and Aesthetic Dermatology. 2013 Jul 1
136 citations
TNF-α Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-α Antagonists to Improve Skin Barrier
Byung Eui Kim, Michael D. Howell, Emma Guttman, Patricia Gilleaudeau, Irma Cardinale, Mark Boguniewicz, James G. Krueger, Donald Y.M. Leung> ;The Journal of Investigative Dermatology. 2011 Jun 1
Atopic dermatitis.
Emma Guttman-Yassky> ;Current Problems in Dermatology. 2007 Jan 1
Join now to see all

Lectures

Atopic Dermatitis
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

Significant Improvements: A New, Promising Long-Term Treatment for EczemaJanuary 25th, 2023
Eczema: Experimental Drug Shows Promise in Treating Atopic DermatitisJanuary 19th, 2023
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term ResultsDecember 9th, 2022
Join now to see all